Sarepta reiterates $1.2B-$1.4B 2026 net product revenue guidance while targeting Cohort 8 data by year-end

Data ReadoutNeutral

AI Analysis

Sarepta reiterates its 2026 net product revenue guidance of $1.2B-$1.4B and targets Cohort 8 data delivery by year-end 2026.

Guidance

$1.2B-$1.4B net product revenue in 2026

Cohort 8 data targeted by year-end 2026

Importance:5/10

Sentiment:

0.00

guidanceclinical_trialrevenue_guidancedata_readout

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on May 7, 2026 3:43 AM